Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
6.93
+0.02 (0.29%)
Feb 21, 2025, 4:00 PM EST - Market closed
Accolade Market Cap
Accolade has a market cap or net worth of $565.39 million as of February 21, 2025. Its market cap has decreased by -43.73% in one year.
Market Cap
565.39M
Enterprise Value
577.80M
1-Year Change
-43.73%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $565.39M, a decrease of -59.74%. That is a compound annual growth rate of -17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 565.39M | 105.27% |
| Dec 31, 2024 | 275.44M | -69.92% |
| Dec 29, 2023 | 915.55M | 63.37% |
| Dec 30, 2022 | 560.40M | -68.11% |
| Dec 31, 2021 | 1.76B | -26.60% |
| Dec 31, 2020 | 2.39B | 70.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |